ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1451

Predictors and Patterns of Fragility Fracture in an Observational Cohort of Patients with Psoriatic Arthritis

Hamzah Amin1 and Marwan Bukhari2, 1Lancaster University, Lancaster, United Kingdom, 2University Hospitals of Morecambe bay NHS foundation trust, Lancaster, United Kingdom

Meeting: ACR Convergence 2024

Keywords: Epidemiology, Fracture, osteoporosis, Psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Data on bone health in patients with psoriatic arthritis (PsA) are scarce  with low numbers being described in the literature , a meta-analysis published in 2020 estimated that patients with psoriatic disease had a higher OR of developing bone fractures (adjusted OR: 1.09; 95% CI: 1.06 to 1.12 (1), but this was based on modest number of small studies with less than a 100 participants. per study . Rheumatoid arthritis is well known be  a predictor of poor bone health and further fragility fractures and is included in the FRAX(tm) fracture prediction tool . We set out to look at the associations between traditional  risk factors, including FRAX™ factors with PsA in an observational cohort referred for Bone mineral density (BMD) estimation. We also looked at the pattern of fragility fracture in this cohort.

Methods: Patients referred for BMD estimation using DEXA between April 2006 and February 2024 to a scanner in the North west of England were used. Patients  demographics as well as other risk factors for fracture were recorded as well as the presence of any fragility fracture, Bone density was estimated in both femoral necks as well as the lumbar spine. The cohort was divided according to the presence of a prevalent fragility fracture and compared, initially using chi squared test for categorical  variables , students T test for continuous variables  and a subsequent logistic model was fitted using fracture as a dependant variable to determine if the expected predictors would be associated with prevalent fracture.

Results: Results: 233 patients were referred to the DEXA scanner in the study period. Mean age was 66.2 years (SD 12.6).178 (78.9%) were female, median BMI was 27.7 (IQR 23.5, 31.3). 86 (36.9%) had a prevalent fracture. The differences and odds ratios are shown in table 1 below. None of the traditional risk factors were associated with fracture in this cohort and while bone density loss was associated with prevalent fracture , this occurred at a lower BMD than would be expected with a T score in the osteopenic range with a T score averaging -1.3 in the femoral neck and -1.1 in the spine. The vast majority of the fractures were not in the femur with only 9 (10%) being femoral. 32(37%) were vertebral fractures. 

Conclusion: In the largest cohort who have been studied to date, fracture in PsA has not  been linked with RX(tm) predictors, Fractures tended to associated with lower bone density. Femoral fractures seemed to less prevalent in the cohort with more vertebral fractures found. This should be taken into consideration when assessing bone health in patients with psoriatic arthritis. Strengths include the large numbers assessed for bone health , limitations include the risk of referral bias , however finding prevalent fractures in osteopenic individuals should raise awareness of the risk in patients with psoriatic disease. 

Ref. 1.Chen et al J Clin Med. 2020 Nov; 9(11): 371

Supporting image 1

Table 1. Predictors of fracture in the cohort


Disclosures: H. Amin: None; M. Bukhari: AbbVie/Abbott, 6, Bristol-Myers Squibb(BMS), 6, Eli Lilly, 6, Gilead, 6, UCB, 6.

To cite this abstract in AMA style:

Amin H, Bukhari M. Predictors and Patterns of Fragility Fracture in an Observational Cohort of Patients with Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/predictors-and-patterns-of-fragility-fracture-in-an-observational-cohort-of-patients-with-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-and-patterns-of-fragility-fracture-in-an-observational-cohort-of-patients-with-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology